Co-Chair, Working Party on behalf of the Association of Anaesthetists, Hampshire, UK.
Department of Anaesthesia, Norfolk and Norwich University Hospital NHS Trust, Norfolk, UK.
Anaesthesia. 2020 May;75(5):654-663. doi: 10.1111/anae.14963. Epub 2020 Feb 3.
These guidelines aim to ensure that patients with adrenal insufficiency are identified and adequately supplemented with glucocorticoids during the peri-operative period. There are two major categories of adrenal insufficiency. Primary adrenal insufficiency is due to diseases of the adrenal gland (failure of the hormone-producing gland), and secondary adrenal insufficiency is due to deficient adrenocorticotropin hormone secretion by the pituitary gland, or deficient corticotropin-releasing hormone secretion by the hypothalamus (failure of the regulatory centres). Patients taking physiological replacement doses of corticosteroids for either primary or secondary adrenal insufficiency are at significant risk of adrenal crisis and must be given stress doses of hydrocortisone during the peri-operative period. Many more patients other than those with adrenal and hypothalamic-pituitary causes of adrenal failure are receiving glucocorticoids as treatment for other medical conditions. Daily doses of prednisolone of 5 mg or greater in adults and 10-15 mg.m hydrocortisone equivalent or greater in children may result in hypothalamo-pituitary-adrenal axis suppression if administered for 1 month or more by oral, inhaled, intranasal, intra-articular or topical routes; this chronic administration of glucocorticoids is the most common cause of secondary adrenal suppression, sometimes referred to as tertiary adrenal insufficiency. A pragmatic approach to adrenal replacement during major stress is required; considering the evidence available, blanket recommendations would not be appropriate, and it is essential for the clinician to remember that adrenal replacement dosing following surgical stress or illness is in addition to usual steroid treatment. Patients with previously undiagnosed adrenal insufficiency sometimes present for the first time following the stress of surgery. Anaesthetists must be familiar with the symptoms and signs of acute adrenal insufficiency so that inadequate supplementation or undiagnosed adrenal insufficiency can be detected and treated promptly. Delays may prove fatal.
这些指南旨在确保在围手术期识别出肾上腺功能不全的患者,并为其充分补充糖皮质激素。肾上腺功能不全主要有两种类型。原发性肾上腺功能不全是由于肾上腺疾病(激素产生腺体衰竭)引起的,而继发性肾上腺功能不全是由于垂体分泌的促肾上腺皮质激素不足,或下丘脑分泌的促肾上腺皮质释放激素不足(调节中心衰竭)引起的。接受生理替代剂量的糖皮质激素治疗原发性或继发性肾上腺功能不全的患者,在围手术期有发生肾上腺危象的重大风险,必须给予氢化可的松应激剂量。除了肾上腺和下丘脑-垂体功能衰竭的患者外,还有许多其他患者因其他医疗状况而接受糖皮质激素治疗。在成人中,每日泼尼松剂量为 5mg 或更大,在儿童中,每日氢化可的松等效剂量为 10-15mg.m 或更大,如果通过口服、吸入、鼻内、关节内或局部途径给药 1 个月或更长时间,可能会导致下丘脑-垂体-肾上腺轴抑制;这种糖皮质激素的慢性给药是继发性肾上腺抑制的最常见原因,有时也称为三级肾上腺功能不全。在重大应激期间进行肾上腺替代需要采取务实的方法;考虑到现有证据,全面的建议是不合适的,临床医生必须记住,在手术应激或疾病后进行的肾上腺替代剂量是在常规类固醇治疗之外的。以前未诊断出肾上腺功能不全的患者有时会在手术后的应激下首次出现。麻醉师必须熟悉急性肾上腺功能不全的症状和体征,以便及时发现和治疗补充不足或未诊断出的肾上腺功能不全。延迟可能是致命的。